ArticleEClinicalMedicine2026

Incidence of hematologic malignancies and mortality associated with GLP-1 receptor agonist and SGLT2 inhibitor use in type 2 diabetes mellitus: results of a retrospective cohort study of electronic health records.

Eric Edward Irons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.